Real-time enrollment status for this her2-positive cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT04482309 |
| Recruiting Status | Recruiting |
| Condition | HER2-positive Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 468 participants |
| Active Locations | 22 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of March 2, 2026: Clinical trial NCT04482309 is currently recruiting participants. This clinical trial study for her2-positive cancer is actively seeking new participants at 22 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04482309 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04482309 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.